EPIX - ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Canada NewsWire

SOUTH SAN FRANCISCO , California and VANCOUVER, Canada , Feb. 6, 2024 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be participating in a virtual fireside chat at the Oppenheimer 34 ^th Annual Healthcare Life Sciences Conference on Tuesday, February 13, 2024, at 12:40 p.m. ET.

David. R. Parkinson, President, and Chief Executive Officer; Peter Virsik, Chief Operating Officer; and David S. Wood, Chief Financial Officer, will host and participate in one-on-one meetings.

A live webcast of the fireside chat can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com . Following the event, the webcast will be archived on the ESSA website for 90 days.

ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com , and follow us on Twitter and LinkedIn .

Contacts

ESSA Pharma, Inc.
Peter Virsik , Chief Operating Officer
778.331.0962
pvirsik@essapharma.com

Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners. com

SOURCE ESSA Pharma Inc

View original content: http://www.newswire.ca/en/releases/archive/February2024/06/c9173.html